Since almost all IBC patients presented with positive axillary lymph node metastasis [21], herein, we investigated whether expression and epigenetic regulation of GPX3 may contribute to the aggressive phenotype IBC versus non-IBC. Here, GPX3 is linked to metastatic malignant neoplasm in the lymph nodes.